Nova Cannabis Inc.
NVACF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.13 | 0.12 | 0.10 | -0.01 |
| FCF Yield | 18.30% | -12.55% | -14.89% | -39.99% |
| EV / EBITDA | 5.33 | 33.15 | -24.96 | 5.74 |
| Quality | ||||
| ROIC | 8.63% | -7.05% | -16.25% | -14.66% |
| Gross Margin | 19.36% | 19.37% | 18.52% | 30.35% |
| Cash Conversion Ratio | 3.87 | 0.01 | 0.48 | 0.10 |
| Growth | ||||
| Revenue 3-Year CAGR | 24.51% | 120.84% | 150.57% | 30.04% |
| Free Cash Flow Growth | 210.83% | 60.91% | -150.53% | -173.42% |
| Safety | ||||
| Net Debt / EBITDA | 2.64 | 14.76 | -5.53 | 1.83 |
| Interest Coverage | 2.14 | -1.90 | -5.87 | -6.98 |
| Efficiency | ||||
| Inventory Turnover | 12.76 | 15.65 | 12.54 | 15.90 |
| Cash Conversion Cycle | 30.85 | 21.09 | 19.27 | 8.67 |